Long‐term clinical outcomes in patients treated with drug‐eluting compared to bare‐metal stents for the treatment of transplant coronary artery disease

Michael S. Lee, Ajay J. Kirtane(Columbia University Irving Medical Center), Ehtisham Mahmud(Cardiovascular Institute of the South), Hsini Liao(Boston Scientific (United States)), Tae‐Hyun Yang(Inje University Busan Paik Hospital), David E. Kandzari(Piedmont Atlanta Hospital)
Catheterization and Cardiovascular Interventions
September 28, 2011
10.1002/ccd.23379
Cited by 12

Related Papers

A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|781
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
|The Lancet|2017|739
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
|The Lancet|2020|593
Clinical Outcomes After Transcatheter Aortic Valve Replacement Using Valve Academic Research Consortium Definitions
|Journal of the American College of Cardiology|2012|591